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summaries
combination chemotherapY
Feasibility study of docetaxel, oxaliplatin and 
capecitabine combination regimen in advanced 
gastric or gastroesophageal adenocarcinoma
In a effort to find a safe and efficacious alternative to docetaxol, 
cisplatin and fluorouracil for treating advanced gastroesophageal 
cancer, Goel and colleagues from Sir Ganga Ram Hospital in 
New Delhi evaluated the new regimen in 21 patients. The overall 
response rate was 29%, and grade 3/4 toxicities included diarr
rhea, handrfoot syndrome, and febrile neutropenia. Median surr
vival was 8.4 months. The authors conclude that the regimen has 
promise in treating advanced esophageal cancer.
thromboembolism
Protein C levels in b-thalassemia major patients in 
the east Nile delta of Egypt
To determine if a protein C deficiency is indicative of a higher 
risk of thromboembolic complications in thalassemic patients, 
Hassan and colleagues from Zigazag University in Egypt mear
sured levels of protein C and other hemostatic and thrombotic 
markers in splenectomized and nonrsplenectomized thalassemic 
patients and health controls. The thalassemic patients, especially 
the splenectomized who had infrequent blood transfusions, had 
lower levels of protein C, suggesting that it plays a major role in 
the hypercoagulable state. Further studies are needed to deterr
mine if prophylactic antithrombotic therapy should be instituted 
in protein Crdeficient thalassemic patients.
proGnostic marKers
Human G-protein gamma 7 in extrahepatic 
cholangiocarcinoma and its clinicopathological 
significance
Wang and colleagues from Changhai Hospital and Ruijin 
Hospital in Shangai studied the expression of Grg 7 gene in 21 
patients with extrarhepatic cholangiocarcinoma. They found 
downrregulated expression, which was associated with the hisr
tological grade of the tumor, and may prove useful in predicting 
prognosis.
thromboembolism
Systemic thromboembolic complications 
after laparoscopic splenectomy for idiopathic 
thrombocytopenic purpura in comparison to open 
surgery in the absence of anticoagulant prophylaxis
In a retrospective analysis, Mohamed and collegues from Egypt 
and Saudi Arabia studied the systemic thromboembolic comr
plications after open and laparascopic splenectomy for primary 
or relapsing ITP in 29 patients, none of whom were given pror
phylactic anticoagulants immediately after surgery. They found 
that patients at greater risk had an exponential rise in the platelet 
count, although factors other than that may be contributing in 
open surgery patients. Further studies of measures to prevent 
these complications are warranted.
anemia
The impact of recently published negative 
erythropoiesis-stimulating agent studies on the 
clinical management of cancer-related anemia at a 
single center
AbdelrRazeq and colleagues at the King Hussein Cancer Center 
in Amman, Jordan, looked at the management of anemia in 995 
cancer patients admitted over the course of one year to determine 
the effect of recent reports suggesting that erythropoiesis stimur
lating agents (ESAs) have a negative impact on disease progresr
sion and survival. ESAs were rarely used in the treatment of aner
mia, and moderate anemia was often not treated, even in patients 
on active chemotherapy. They suggest that better guidelines are 
needed in that subgroup of patients.
